Santral obezite göstergesi olan bel çevresinin alt üriner sistem semptomları, erektil disfonksiyon ve metabolik sendrom komponentleri ile ilişkisi

Amaç: Bu çalışmada santral obezite göstergesi olan bel çevresinin alt üriner sistem semptomları, erektil disfonksiyon ve metabolik sendrom komponentleri ile olan ilişkisini incelemeyi amaçladık. Gereç ve yöntem: Orta-şiddetli işeme şikayetleri ile başvurmuş, daha önceden Benign Prostat Hiperplazisi tanısı olmayan ve Prostat spesifik antijen değeri

The relationships between waist circumference as an indicator of central obesity and lower urinary tract symptoms, erectile dysfunction and metabolic syndrome components

Objectives: In this study, we aimed to evaluate the relationship between waist circumference, which is as an indicator of central obesity, and lower urinary tract symptoms, erectile dysfunction and metabolic syndrome components. Materials and methods: The data of 52 patients with moderate-severe lower urinary tract symptoms, who had no previous diagnosis of benign prostatic hyperplasia and prostate specific antigen <4 ng/ml were retrospectively analyzed. The patients were divided in 3 subgroups according to the waist circumference (<94 cm, 94-102 cm, >102 cm). Age, weight, urine flow rates, prostate volume, and prostate specific antigen value and lipid profiles were separately determined for all patients. Data on chronic systemic diseases and erectile function was also evalu- ated and possible relations between them were investigated. Results: The mean age of patients was 60,6±7,8 years. It was determined that diabetes in 17 (%32,69), hypertension in 22 (%42,30), coronary artery disease in 13 (%25) and erectile dysfunction in 24 (%46.15) patients. Positive correlations were found between waist circumference and the parameters of age, International Prostate Symptom Score, body weight, prostate volume, triglyceride and LDL-cholesterol levels. Nevertheless, there was a negative correlation between waist circumference and urine flow rates. While the data of all subgroups were compared, it was seen that increased waist circumference was with worsened lower urinary tract symptoms and sexual function. Conclusions: Increased waist circumference had negative impacts on lower urinary tract symptoms and sexual functions, and it was with increasing frequency of diabetes, coronary heart disease, hypertension and metabolic syndrome.

PDF

___

1. Rohrmann S, Smit E, Giovannucci E et al: Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int J Obes (Lond) 2005; 29(3):310-6.
2. Fitzgerald MP, Link CL, Litman HJ et al: Beyond the lower urinary tract: the association of urologic and sexual symptomps with common illnesses. Eur Urol 2007; 52(4):407- 12.
3. Joseph MA, Harlow SD, Wei JT et al: Risk factors for lower urinary tract symptoms in a population based sample of African-American men. Am J Epidemiol 2003; 157(6):906- 12.
4. Michel MC, Mehlburger L, Schumacher H et al: Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol 2000; 163(10): 1725-31.
5. Booth ML, Hunter C, Gore CJ, Bauman A, Owen N. The relationship between body mass index and waist circumference: implications for estimates of the population prevalence of overweight. Int J Obes Relat Metab Disord 2000; 24(9):1058-61.
6. Kaplan S, Fisch H, Berriman SJ, Saini R, Lee R, Te AE. Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms, sexual dysfunction, and components of the metabolic syndrome. Program and abstracts of the American Urological Association 2007 Annual Meeting; May 19-24, 2007; California, Abstract 1508.
7. Türkiye metabolik sendrom araştırması.Metabolik Sendrom Araştırma Grubu, 2005, Kozan Ö, Oğuz A ve arkadaşları; http://www.tkd.org.tr/SunuMerkezi/?s= 233E3F2- B232E242A39, 2008
8. Lahti-Koski M, Pietinen P, Heliövaara M and Vartiainen E. Associations of body mass index and obesity with physical activity, food choices, alcohol intake, and smoking in the 1982–1997 Finrisk Studies. Am J Clin Nutr 2002; 75(6):809-817.
9. James WP. The epidemiology of obesity. Ciba Found Symp 1996; 201(1): 1-11
10. Kushner RF. Medical management of obesity. Semin Gastrointest Dis 2002; 13(1): 123-32 Dicle Tıp Derg / Dicle Med J
11. Onat A, Ceyhan K, Basar O, Erer B, Toprak S, Sansoy V. Metabolic syndrome: Major impact on coronary risc in a population with low cholesterol levels-prospective and crosssectional evaluation. Atherosclerosis 2002;165(2): 285-92.
12. Chapple CR, Roehrborn CG. A shifted paradigm for the further understanding, evaluation and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol 2006 ; 49(4): 651-8.
13. Hammarsten J, Hogstedt B. Clinical, anthropometric, metabolic and insüline profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press 1999; 8(1): 29-36.
14. Rohrmann S, Smit E, Giovannucci E, Platz EA. Association of obesity with lower urinary tract symptoms and noncancer prostate surgery in The Third National Health and Examination Survey. Am J Epidemiol 2004; 159(3): 390-7.
15. Kupelian V, McVary KT, Kaplan SA,et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey. J Urol 2009; 182(5): 616-24.
16. Temml C, Obermayr R, Marszalek M, Rauchenwald M, Madersbacher S, Ponholzer A. Are lower urinary tract sypmtoms influenced by metabolic syndrome? Urology 2009; 73(4): 544-8.
17. Bal K, Oder M, Sahin AS, et al. Prevalence of metabolic syndrom and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction. Urol 2007; 69(3); 356-60.
18. Demir T, Demir O, Kefi A, Comlekci A, Yesil S, Esen A. Prevalence of erectile dysfunction in patients with meta- bolic syndrome. Int J Urol 2006;13(3):385-8.